GlassScriptPhysician profile
Ruth Avigan Mann
NPI 1073674594
$1,252.64
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $94.50 · 2021: $131 · 2022: $201 · 2023: $251 · 2024: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $172.74 | 2019-2024 | Auvi-Q |
| Cranial Technologies, INC | $153.26 | 2019-2024 | Doc Band |
| Glaxosmithkline, LLC. | $142.15 | 2019-2024 | Bexsero, Rotarix, Pediarix |
| Corium, LLC | $137.22 | 2023-2024 | Azstarys, Azstarys |
| Sanofi Pasteur INC. | $106.69 | 2022-2024 | |
| Ironshore Pharmaceuticals INC. | $96.01 | 2019 | |
| Pfizer INC. | $91.33 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.35 | 2020-2021 | |
| Cumberland Pharmaceuticals, INC. | $59.28 | 2022-2024 | Kristalose |
| Merck Sharp & Dohme LLC | $35.27 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $32.25 | 2022 | |
| Supernus Pharmaceuticals, INC. | $24.28 | 2022 | |
| Biogen, INC. | $23.04 | 2024 | Spinraza |
| Genentech USA, INC. | $22.16 | 2019 | |
| Sobi, INC | $20.10 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $18.92 | 2023 | Flucelvax Quadrivalent |
| Tris Pharma INC | $17.68 | 2021 | |
| Aytu Biopharma, INC. | $14.67 | 2021 | |
| Adlon Therapeutics L.P. | $13.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.